连续流左心室辅助装置支持期间致死性神经功能障碍
神经功能障碍发生前LVAD支持中位时间为230天,神经功能障碍至死亡中位时间3.5天,早期转归最常见病因为实质出血(76.7%)。Cox多变量回归显示致死性神经功能障碍预测因素包括年龄、缺血性心力衰竭病因、卒中史和较长术中主动脉阻断时间。
要点
- CF-LVAD支持患者神经功能障碍发生率为26.8%,其中9.1%死亡。
- 神经功能障碍至死亡中位时间仅3.5天,早期转归以实质出血为主(76.7%)。
- 年龄、缺血性心衰、卒中史和较长主动脉阻断时间预测致死性神经功能障碍。
核心结论
- 本研究阐明了CF-LVAD支持期间死于神经功能障碍患者的特征和危险因素,需进一步研究降低致死性神经功能障碍发生率。
主要发现
- 神经功能障碍发生于141例(26.8%),其中48例(9.1%)随后死亡。
- 神经功能障碍发生前LVAD支持中位时间230天(范围3至2,422天),神经功能障碍至死亡中位时间3.5天(范围0至55天)。
- 实质出血是早期转归最常见原因(76.7%)。
- Cox多变量回归分析显示致死性神经功能障碍预测因素为年龄、缺血性心力衰竭病因、卒中史和较长术中主动脉阻断时间。
临床怎么用
- 对CF-LVAD支持患者应关注年龄、缺血性心衰病因、卒中史和术中主动脉阻断时间等致死性神经功能障碍危险因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: During continuous-flow left ventricular assist device (CF-LVAD) support, neurologic dysfunction (ND) is a common complication and can be fatal. Few reports provide detailed data on neurologic mortality in such patients. Therefore, we examined ND-related mortality during CF-LVAD support. METHODS: Between November 2003 and March 2016, 526 patients underwent implantation of a CF-LVAD (403 HeartMate II [Thoratec, Pleasanton, CA] and 123 HVAD [HeartWare International, Framingham, MA]) at our center. We categorized ND as hemorrhagic or ischemic and recorded resulting deaths. Records were reviewed to determine preoperative demographics, perioperative variables, prevalence and causes of postimplantation ND, duration of support until ND, time from ND to death, laboratory data and medications at the time of ND, post-ND treatment procedures, and causes of hemorrhagic ND. We also performed Cox multivariable logistic regression analysis to identify predictors of ND-related mortality by calculating odds ratios and confidence intervals. RESULTS: Neurologic dysfunction occurred in 141 patients (26.8%), 48 (9.1%) of whom subsequently died. Median duration of left ventricular assist device support before ND was 230 days (range, 3 to 2,422), and median time from ND to death was 3.5 days (range, 0 to 55). Parenchymal hemorrhage was the most frequent cause of early conversion (76.7%). In the Cox multivariable regression analysis, predictors of fatal ND were age, ischemic cause of heart failure, history of stroke, and longer intraoperative aortic cross-clamp time. CONCLUSIONS: Our study elucidates the characteristics and risk factors of patients who died of ND during CF-LVAD support. Further studies are required to find ways to decrease the incidence of fatal ND during CF-LVAD support.
引用
- Kawabori M, Conyer RT, Kurihara C, et al. Fatal Neurologic Dysfunction During Continuous-Flow Left Ventricular Assist Device Support. Ann Thorac Surg. 2018. PMID: 30465757. doi:10.1016/j.athoracsur.2018.10.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。